ArticleCost effectiveness and resource allocation : C/E2025
Post-COVID-19 condition patients' utilisation of healthcare resources after implementation of an integrated care unit.
Article in Cost effectiveness and resource allocation : C/E, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe economic effects of post-COVID-19 condition (PCC) remain uncertain despite clearer clinical factors, posing challenges for healthcare professionals. This article investigates the demographic and clinical characteristics of PCC patients and compares their healthcare resource utilization in comparison to a patient cohort representative of the population.
methodsA retrospective and cohort-comparative observational study was conducted, comparing PCC population before and after diagnosis with a control group. Demographic and clinical variables were analysed to describe the population. Economic analysis was performed to evaluate the resource costs in procedures and primary, secondary and emergency care.
resultsPCC patients (N = 341) were older with higher cardiovascular risk factors compared to controls (N = 49,078). There were differences in the socio-economic distribution between male and female in the PCC patients. Hypertension and diabetes mellitus type 2 were the most common chronic diseases observed among the case patients. PCC patients were four times as costly as control patients, with increased utilisation of healthcare resources. However, post-diagnosis PCC patients showed a reduction in costs, primarily driven by decreased primary care visits and hospitalisations.
conclusionsCoordinated care for PCC patients leads to cost reductions and improved resource utilisation. Further research should investigate long-term health outcomes and establish causal relationships between COVID-19 sequelae and healthcare resource utilisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.